Zurich Cantonal Bank
HAE icon

Zurich Cantonal Bank’s Haemonetics HAE Stock Holding History

Zurich Cantonal Bank’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,156
Closed -$1.13M – 2979
2025
Q4 		$1.13M Buy
+14,156
New +$951K ﹤0.01% 1269

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Zurich Cantonal Bank's HAE Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Haemonetics (HAE) in Q1 2026: 18,339 shares worth $1.03M. The stake represents ﹤0.01% of the portfolio and ranks #1414 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in HAE as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in HAE in Q2 2013 and has held it in 47 quarters since. The position peaked at $8.39M in Q3 2013. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Zurich Cantonal Bank held 18,339 shares of Haemonetics worth $1.03M as of Q1 2026.
  • Haemonetics was a new Zurich Cantonal Bank position in Q1 2026.
  • Haemonetics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1414 holding.
  • Zurich Cantonal Bank first reported a position in Haemonetics in Q2 2013 and has held it in 47 quarters since.
  • Zurich Cantonal Bank's Haemonetics position peaked at $8.39M in Q3 2013.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.